|Bid||83.7700 x 100|
|Ask||83.7800 x 500|
|Day's Range||83.2600 - 83.8100|
|52 Week Range||66.9300 - 86.9000|
|PE Ratio (TTM)||31.49|
|Dividend & Yield||2.72 (3.28%)|
|1y Target Est||N/A|
Specialty pharmacy firm US Bioservices Corp has agreed to pay $13.4 million to settle U.S. government claims that it pushed patients to refill prescriptions of Novartis AG's iron overload drug Exjade in exchange for referrals from the Swiss drugmaker. US Bioservices, a unit of drug wholesaler AmerisourceBergen , agreed to pay $10.6 million to the federal government and $2.8 million to states, according to a filing on Tuesday in Manhattan federal court by Acting U.S. Attorney Joon Kim.
Late last week, Biogen (BIIB) and six other pharma and biotech stocks were in the news due to the pricing of their multiple sclerosis ("MS") drugs.
These are the stocks posting the largest moves before the bell.